FG
Insider buying
Faisal Ghiath Sukhtian bought $50K of Outlook Therapeutics, Inc. (OTLK) stock
Faisal Ghiath Sukhtian, Dir of Outlook Therapeutics, Inc. (OTLK), bought 122,174 shares of OTLK stock worth $50K, per an SEC Form 4 filed May 27, 2026.
It was an open-market purchase.
The trade was reported on May 27, 2026.
OTLK has moved -0.1% since the trade date, from $0.59 to $0.59 (Oct 12, 2026 close).
- Traded
- May 27, 2026
- Disclosed
- May 27, 2026
- Filing delay
- 0 days
- Price since
- -0.1%
- Role
- Dir
- Source
- SEC Form 4
More OTLK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.